Is Gleason 3+3=6 really cancer—or is it something less dangerous? In this episode of UroNurse News, hosted by Vic Senese, RN, BSN, FAUNA, we tackle one of the most debated topics in urology today.

The Gleason score has long been used to classify prostate cancer, but when it comes to Gleason 6 (Grade Group 1), the conversation is evolving. Many experts argue that this low-grade diagnosis behaves very differently from more aggressive forms of prostate cancer—raising the question: should it even be called cancer?

In this video, you’ll learn:

• What Gleason 3+3=6 actually means under the microscope
• Why it is still classified as cancer by organizations like the American Urological Association
• The growing debate among experts about reclassifying low-risk prostate disease
• How active surveillance is changing the way we manage low-risk prostate cancer
• What this diagnosis means for patients—and why overtreatment is a real concern

This episode is essential viewing for patients, caregivers, and healthcare professionals navigating prostate cancer decisions. Understanding the difference between low-risk and aggressive disease can help avoid unnecessary treatment and improve quality of life.

👉 Subscribe to my channel for more expert urology insights:
https://www.youtube.com/@UroNurse1

The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.